0:00
33:30
Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde.
Together, they talk about how AI could transform drug discovery and development at a large biopharma company—and how a company might have to adapt to harness AI; modalities they’re excited about; and Greg’s do’s and don’ts for startups looking to partner with a company like BMS.
D'autres épisodes de "Raising Health"
Ne ratez aucun épisode de “Raising Health” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.